Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

<< Previous

Bullboard Posts

Next >>

Post by scarlet1967on Apr 06, 2021 8:42am

100 Views

Post# 32940329

Good PR

Galectin Therapeutics (NASDAQ:GALT) announces the launch of NAVIGATEnash.com, its dedicated trial website to educate patients and physicians about liver cirrhosis resulting from non-alcoholic steatohepatitis (NASH).
The website also aims to support NAVIGATE, the company’s innovative, seamless adaptive Phase 2b/3 study in NASH cirrhosis, the end stage of non-alcoholic steatohepatitis (NASH), which is characterized by the presence of excess fat in the liver.
The NAVIGATE Study is expected to enroll about 315 NASH patients in the Phase 2b part of the trial at about 130 sites in 12 countries in North America, Europe, Asia and Australia.
The goal of the study is to prevent the development of esophageal varices, thought to be an early sign of more serious complications of NASH cirrhosis.Galectin Therapeutics launches navigatenash.com https://seekingalpha.com/news/3679451-galectin-therapeutics-launches-navigatenashcom